The earnings call highlighted strategic changes such as the proposed conversion to a BDC and an expanded credit facility, which could offer growth and diversification opportunities. However, these positives were offset by significant financial challenges, including a net loss, underperforming loans, and increased credit reserves, reflecting ongoing difficulties in the cannabis market.
Company Guidance -
Q3 2025
During the second quarter 2025 earnings call for Advanced Flower Capital, the company provided guidance on several key metrics and strategic initiatives. The firm reported distributable earnings of $0.15 per basic weighted average share of common stock, with a declared dividend of $0.15 per share. The net interest income totaled $6.2 million, while the GAAP net loss was $13.2 million or $0.60 per share. The portfolio consisted of $359.6 million in principal outstanding across 15 loans, with a weighted average portfolio yield to maturity of approximately 17% as of August 1, 2025. A significant focus was on the proposed conversion from a Real Estate Investment Trust (REIT) to a Business Development Company (BDC), aiming to broaden investment opportunities beyond real estate-backed assets. The management also highlighted challenges with underperforming loans, noting a $44 million CECL reserve, and discussed ongoing legal proceedings related to enforcing rights under credit facilities. The call emphasized the potential impact of cannabis rescheduling discussions on the market, which could bolster asset valuations and improve loan recoveries.
Proposed Conversion to a Business Development Company (BDC)
Advanced Flower Capital announced its intention to convert from a REIT to a BDC. This conversion is expected to expand the investment universe and allow the company to lend to operators without real estate coverage, potentially increasing opportunities.
Expansion of Senior Secured Revolving Credit Facility
During the second quarter of AFC expanded a senior secured revolving credit facility from $30 million to $50 million, with an additional $20 million commitment from the facility's lead arranger.
Potential Rescheduling of Cannabis
There is talk of cannabis rescheduling being considered by the Trump administration, which could increase the supply of capital for cannabis companies and lead to potentially better recoveries for troubled loans.
AFC Gamma (AFCG) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AFCG Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 14, 2025
$4.56
$4.39
-3.73%
May 14, 2025
$5.59
$5.30
-5.19%
Mar 13, 2025
$7.91
$6.30
-20.35%
Nov 13, 2024
$8.47
$8.28
-2.24%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does AFC Gamma (AFCG) report earnings?
AFC Gamma (AFCG) is schdueled to report earning on Nov 05, 2025, Before Open (Confirmed).
What is AFC Gamma (AFCG) earnings time?
AFC Gamma (AFCG) earnings time is at Nov 05, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.